Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
771.12 | -49,84% | -29,25% | 708.637,05 | 0,66% | 2,63% |
|
NYSE:JNJ
Johnson & Johnson
|
154.28 | 0% | 0% | 367.427,71 | 3,25% | 2,71% |
|
NYSE:MRK
Merck
|
130.88 | -10,39% | 2,75% | 333.646,57 | 2,34% | -19,03% |
|
NYSE:PFE
Pfizer
|
28.92 | 7,74% | 37,79% | 163.311,21 | 5,83% | -9,31% |
|
NasdaqGS:VRTX
Vertex Pharmaceuticals Inc
|
440.64 | -0,38% | 7,51% | 112.895,78 | 0% | 30,14% |
|
NasdaqGS:REGN
Regeneron Pharmaceuticals
|
967.98 | -29,3% | -23,27% | 105.534,68 | 0% | 13,9% |
|
NYSE:BMY
Bristol-Myers Squibb
|
44.11 | 59,85% | 70,07% | 90.307,31 | 5,39% | 13,54% |
|
NYSE:ZTS
Zoetis
|
173.71 | 27,68% | 43,5% | 79.066,82 | 1% | 11,19% |
|
NasdaqGS:ALNY
Alnylam Pharmaceuticals Inc
|
151.22 | 0% | 0% | 18.644,89 | 0% | 0% |
|
NYSE:BAX
Baxter International Inc
|
35.17 | 81,85% | 109,28% | 18.054,43 | 3,27% | -3,14% |
|
NasdaqGS:VTRS
Viatris Inc
|
11.02 | 5,13% | 15,66% | 13.324,53 | 4,34% | -8,55% |
|
NasdaqGS:UTHR
United Therapeutics
|
272.22 | -10,71% | -1,33% | 11.803,71 | 0% | 5,22% |
|
NYSE:CTLT
Catalent
|
55.25 | -57,27% | -6,76% | 10.100,49 | 0% | -10,41% |
|
NasdaqGS:CYTK
Cytokinetics
|
59.92 | 0% | 0% | 6.707,63 | 0% | 0% |
|
NasdaqGS:IONS
Ionis Pharmaceuticals
|
37.62 | -.156,68% | -.149,23% | 5.756,54 | 0% | 0% |
|
NasdaqGS:BCPC
Balchem
|
156.63 | -9,31% | -0,59% | 5.026,29 | 0,51% | 5,85% |
|
NasdaqGS:MDGL
Madrigal Pharmaceuticals
|
217.17 | 0% | 0% | 4.409,78 | 0% | 0% |
|
NYSE:PRGO
Perrigo Co PLC
|
30.10 | 35,17% | 58,31% | 4.186,4 | 3,65% | -10,73% |
|
NasdaqGS:NEOG
Neogen
|
13.41 | 133,55% | 233,03% | 2.692,43 | 0% | -1,7% |
|
NasdaqCM:CORT
Corcept Therapeutics
|
27.54 | -34,78% | -10,92% | 2.552,83 | 0% | 2,03% |
